Keynote Plenary Speakers

Bernard Cribier (France)


Bernard Cribier is the Head of Department, Dermatology & Dermatopathology at the Strasbourg University Hospital, France. He is a certified Dermatologist since 1989 and has a PhD in Virology. His main fields of interest are dermatopathology, rosacea and history of dermatology.

He has been the Editor-in-Chief of the Annales de Dermatologie et de Vénéréologie since 2010. He is the author of 389 indexed articles (H index: 48) and 72 book chapters, including a book dedicated to clinicopathological correlation, published in 2015: “Dermatologie, de la Microscopie à la Clinique”. In the field of dermatopathology, he is the coordinator of the French network for adnexal carcinomas (CARADERM). All his academic efforts are dedicated to teaching dermatopathology to both dermatologists and pathologists and to emphasise the critical role of dermatopathology in dermatology.

Ann Goossens (Belgium)


An(nie) Goossens. Mother of 3 sons, and grandmother of 4 grandchildren.
She graduated in 1973 as a Pharmacist from the Katholieke Universiteit of Leuven, Belgium and shortly afterwards obtained the Certificate of Advanced Studies in Cosmetology from the University of Nantes, France in 1974. During the year from 1974-1975 she performed clinical research with A.A. Fisher, clinical professor at the New York University, New York, USA. From 1975 until 1982 she was a scientific co-worker in the Department of Dermatology of the Katholieke Universiteit of Leuven, Belgium and became Doctor in Medical Sciences (1982). In 1984 she got a permanent appointment to the staff of the Department of Dermatology of the Katholieke Universiteit of Leuven, where she became a lecturer in 1987, associated professor in 1990, and professor in 1996. She was also, until 2011, guest professor at the Faculty of Pharmacy at the University of Antwerp.

She is member of the Belgian Environmental Contact Dermatitis Group (from 1990 to 1993 secretary, from 1993 to 1996 president, and from 2004 to 2007 again, the “Groupe d’Etudes et de Recherche en Dermato-Allergologie de Contact” (GERDA, France), the European Environmental Contact Dermatitis Research Group (EECDRG) (secretary from 1993 to 1999, president from 1999 to 2002), the European Society of Contact Dermatitis (ESCD) (President 2010-2012), and the International Contact Dermatitis Research Group (ICDRG). She is an honorary member of the Mexican Academy of Dermatology and the Society of Dermatology in Argentina, and is a corresponding member of the Belgian, Swedish and Portuguese Dermatological Societies.
She is also a Member of the Superior Health Council, Belgium. Since 1998 she is also a member of the editorial board of “Contact Dermatitis”, and has been, or is in the board of the “Annali Italiani di Dermatologia”, “Allergologia and Immunopathologia”, “International Journal of Dermatology and Clinical Research”, and “Cosmetics”. She is the author of numerous articles in the field of contact dermatitis.

Christopher Griffiths (United Kingdom)


Chris Griffiths qualified in Medicine from St Thomas’ Hospital Medical School, London. He trained in Dermatology at St Mary’s Hospital, London, and at the University of Michigan, USA, where he was on Faculty for 4 years. He was appointed to the Foundation Chair in Dermatology at the University of Manchester in 1994 and is an honorary consultant dermatologist at Salford Royal NHS Foundation Trust. At the University of Manchester he has held several senior posts including Faculty Research Dean and Director of the Manchester Academic Health Science Centre. He currently leads for precision medicine in the UK Government’s Manchester Devolution initiative. Chris received a lifetime achievement award from the American Skin Association in 2009 and the Sir Archibald Gray Medal for outstanding service to British Dermatology in 2015. He is an NIHR Senior Investigator, Fellow of the Academy of Medical Sciences and elected Member of Academia Europaea.

Professor Griffiths is a past-President of the British Association of Dermatologists, European Dermatology Forum, British Society for Investigative Dermatology and International Psoriasis Council. He is an Executive Board member of both the European Society for Dermatological Research and International League of Dermatological Societies. He has published 561 Pubmed cited articles in scientific journals (h-index 88), and is Editor-in-Chief of Rook’s Textbook of Dermatology. Chris has long-standing research interests in all aspects of psoriasis and skin ageing; he was amongst the first to demonstrate the ability of topical retinoid to repair photoaged skin.

Colm O’Mahony (United Kingdom)


Prof. Colm O’Mahony is a Consultant physician. He deals with sexually transmitted infections, HIV / AIDS.
He first qualified in Science (Microbiology) in 1975. He did an MD in Immunology and ended up in a VD Clinic in Dublin, doing a session, and there – like St Paul on the road to Damascus, enlightenment. Here was just the job for your average repressed Irish Catholic. There was sex, shame, guilt, anxiety, confession, forgiveness and penance. He had found his niche! As there was not enough sex in Ireland he then trained in England where he got a consultant post.

He was elected as Chairman of the Association of GU Doctors in 2001 and to the British HIV Association executive committee in 2005. He was the chairman of the British Association for Sexual Health and HIV media group and became chair of the EADV media committee in 2009. He was the UK representative on the EADV. He wrote a regular piece in the Journal of Sexually Transmitted Infections, entitled “Chester Chronicles” and an editorial “View from the frontline” in the INT J STD AIDS. He has lectured extensively in Europe, Australia, Malaysia, Hong Kong, Singapore, China, Korea and even in Jeddah (Feb 2012), where apparently there are no STD’s…

Nanja van Geel (Belgium)


Nanja van Geel, M.D., Ph.D is a dermatologist and an associate Professor at Ghent University Hospital in Belgium. She directs the pigmentary disorder related activities at the department of Dermatology which incorporates a specialty clinic for the diagnosis and treatment of patients with vitiligo. She participated in drafting general guidelines (e.g. national/European) and recommendations for vitiligo (e.g. Lancet paper) with a particular interest in surgical management of vitiligo and outcome measurement instruments.

For her PhD she performed the first double blind randomised controlled trial to evaluate non cultured epidermal cellular grafting for vitiligo. She has authored multiple international papers and book chapters, received several scientific awards and serves on several international committees related to vitiligo (e.g. VETF, VGICC). She is steering the international Vitiligo Score Working group since 2015 for which she received national and international grant supports. The activities of this working group are related to the development and validation of outcome measurement instruments for vitiligo with the ultimate future goal to achieve a worldwide consensus to consistently apply a single valid, reliable, and feasible instrument to measure vitiligo severity in daily practice and all future clinical trials (e.g. Vitiligo Extent Score VES;

Stephan Weidinger (Germany)


Stephan Weidinger is currently Professor for Dermatogenetics at the Christian-Albrechts-University as well as Vice-Head of the Department of Dermatology at the University Hospital Schleswig-Holstein, Campus Kiel, Germany, where he supervises the section for inflammatory skin diseases. He qualified as a physician from the University of Regensburg, Germany, and following this he received his MD and PhD from the Technische Universität in Munich. Prior to his current position, Professor Weidinger held a senior physician position at the Department of Dermatology and Allergy, Technische Universität Munich, where he led the atopic dermatitis and psoriasis outpatient departments.

In addition to his clinical and research roles, Professor Weidinger is an Associate Editor of the “Journal of Allergy and Clinical Immunology “, the “Journal of Investigative Dermatology” and “Allergy”, as well as Managing Editor of “Archives of Dermatological Research” and Edotorial Board Member of the “Journal of the European Academy of Dermatology and Venereology”. He acts as reviewer for a range of prestigious journals and international funding bodies. Since 2010, he has been a member of the BEEP (Barrier Enhancement for Eczema Prevention) and HOME (Harmonizing Outcome Measures for Eczema) international scientific advisory boards. Professor Weidinger has also been presented with multiple awards including the Langerhans Award of the German Society for Dermatological Research (ADF), the PhARF Award 2014, the European Centre for Allergy Research Foundation (ECARF) Award 2012, the Allergopharma Award 2010, a Heisenberg fellowship of the German Research Council in 2009, and the Herxheimer Award of the German Society for Allergy and Clinical Immunology 2006.

His main research interests lie in the molecular mechanisms and treatment of allergic and chronic inflammatory skin diseases, and he has published numerous peer-reviewed publications on this and other related topics. He currently is principal investigator of the Epidemiology Cluster Laboratory in the German Excellence Cluster “Inflammation at Interfaces”, leads a project of the sysINFLAME systems medicine project funded by the e:Med research concept of the German Ministry for Health, directs several large-scale collaborative research projects, and is principal investigator in several clinical trials.

Back to top